Near real-time data on the human neutralizing antibody landscape to influenza virus in late 2025 to early 2026 to inform vaccine-strain selection in February 2026
Briefly, this study used sequencing-based neutralization assays to measure titers to influenza viruses with HAs from seasonal H3N2 and H1N1 viruses representative of those circulating in late 2025 and early 2026 against a set of human sera collected in mid to late 2025.
The subdirectory ./non-pipeline_analyses/ has auxillary analyses outside of the main pipeline. See the README files within that subdirectory for details.